| | Variable | VA + CMS count/percent |
| | Outcomes | | | | Constipation identification through diagnosis | 6,872 | 4.49% | | Constipation identification through procedure | 43 | 0.03% | | Constipation identification through medication | 17,810 | 11.65% |
| | Medications | | | | Laxative use prior year | 28,143 | 18.41% | | Constipating Meds-Prior Use from 1 year to 61 days | 9,076 | 5.94% | | Constipating Meds-Prior Use from 60 to 31 days | 3,431 | 2.24% | | Constipating Meds-Prior Use from 30 to 1 day | 132,303 | 86.53% | | Laxative use prior to opioid era | 32,593 | 21.32% | | Prevalent laxative | 9,446 | 6.18% | | Preventative laxative | 7,514 | 4.91% |
| | Medical conditions | | | | Prior constipation diagnosis | 13,071 | 8.55% | | Prior constipation procedure | 44 | 0.03% | | Impaction | Less than 11 | 0.00% | | Hemorrhoids | 15,160 | 9.91% | | Gastrointestinal anatomical trauma | 556 | 0.36% | | Cerebrovascular disease | 19,253 | 12.59% | | Chronic kidney disease | 23,051 | 15.08% | | Colitis | 1,033 | 0.68% | | Congestive heart failure | 25,960 | 16.98% | | Coronary artery disease | 63,509 | 41.54% | | Diabetes mellitus | 60,628 | 39.65% | | Diabetic neuropathy | 5,639 | 3.69% | | Fibromyalgia | 4,030 | 2.64% | | Gastroparesis | 899 | 0.59% | | Hypercalcemia | 750 | 0.49% | | Hyperkalemia | 4,838 | 3.16% | | Hyperparathyroidism | 852 | 0.56% | | Hypertension | 126,939 | 83.02% | | Irritable bowel syndrome | 1,236 | 0.81% | | Megacolon | 57 | 0.04% | | Migraine headache | 6,637 | 4.34% | | Multiple sclerosis | 348 | 0.23% | | Myocardial infarction | 5,103 | 3.34% | | Myopathies | 7,396 | 4.84% | | Osteoarthritis | 56,514 | 36.96% | | Parkinson’s disease | 3,519 | 2.30% | | Revascularization CABG | 18,570 | 12.14% | | Rheumatoid arthritis | 3,166 | 2.07% | | Stable angina | 13,540 | 8.86% | | Stroke | 11,193 | 7.32% | | Unstable angina | 17,952 | 11.74% |
|
|
